Evidence map›Paper›PMID 42110238›Full record

ArticleFrontiers in public health2026

An outlook on clinical and demographic variables in patients with severe COVID-19 across different waves in Mexico and SARS-CoV-2 variants: data from two high-specialty centers.

Ingrid Fricke-Galindo, Ilse Adriana Gutiérrez-Pérez, Diana Lizbeth Ortíz-Farias, Esperanza Figueroa-Hurtado, Iris Paola Guzmán-Guzmán, Gloria Pérez-Rubio, Ivette Buendía-Roldán, Leslie Chavez-Galan, Arturo Cortés-Telles, Ramcés Falfán-Valencia

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ingrid Fricke-GalindoPneumogenomics Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Ilse Adriana Gutiérrez-PérezFaculty of Chemical-Biological Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, Mexico.
Diana Lizbeth Ortíz-FariasClínica de Enfermedades Respiratorias, Hospital Regional de alta Especialidad de la Península de Yucatán-IMSS Bienestar, Mérida, Yucatán, Mexico.
Esperanza Figueroa-HurtadoClínica de Enfermedades Respiratorias, Hospital Regional de alta Especialidad de la Península de Yucatán-IMSS Bienestar, Mérida, Yucatán, Mexico.
Iris Paola Guzmán-GuzmánFaculty of Chemical-Biological Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, Mexico.
Gloria Pérez-RubioPneumogenomics Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Ivette Buendía-RoldánTranslational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Leslie Chavez-GalanLaboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Arturo Cortés-TellesClínica de Enfermedades Respiratorias, Hospital Regional de alta Especialidad de la Península de Yucatán-IMSS Bienestar, Mérida, Yucatán, Mexico.
Ramcés Falfán-ValenciaPneumogenomics Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Throughout the COVID-19 pandemic, there was variability in outcomes and in the clinical and demographic characteristics of patients with severe disease. We aimed to compare clinical and demographic variables at hospital admission among patients with severe COVID-19 at two high-specialty centers in Mexico during the pandemic waves, accounting for relevant virus variants and patients' vaccination status. Methods: This retrospective, descriptive study included medical records of 1,425 patients hospitalized with COVID-19 (March 2020-November 2022) at the National Institute of Respiratory Diseases (INER, Mexico City, Mexico) and the Regional High Specialty Hospital of the Yucatán Peninsula-IMSS Bienestar (Merida, Yucatán, Mexico). The comparison was performed between the 1st wave, the 2nd and 3rd waves, and the 4th to 6th waves in Mexico, among the pre-dominant SARS-CoV-2 variants (Delta and Omicron), and vaccination status during the Omicron stage. Results: At the 1st wave, patients were pre-dominantly male and younger; whereas in the 4th to 6th waves, a high frequency of subjects with heart disease was observed. The longest hospital stay (median 23 days) and the highest percentage of invasive mechanical ventilation (81.02%) were observed during the 2nd and 3rd waves. Heart diseases and D-dimer were relevant during the Omicron stage. Clinical and demographic variables were similar between unvaccinated and vaccinated subjects, although the mortality was lower in the vaccinated group. Conclusions: These differences in the studied variables across pandemic waves and SARS-CoV-2 variants help explain the variability in clinical outcomes throughout the COVID-19 pandemic.

Indexed as

COVID-19SARS-CoV-2AdultAgedFemaleHospitalizationHumansMaleMexicoMiddle AgedRetrospective StudiesSeverity of Illness IndexVaccinationclinical variablesCOVID-19pandemicSARS-CoV-2vaccine

Identifiers

PMID42110238
PMCPMC13149431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.